jakeDM, I am NOT pointing the finger to RONIN at all. And I wrote myself that PPHM 'down-played' the IP/Pipeline results. Dr. Garnick said that he knew when to kill a drug, well I hope that didn't mean anything other then what we believe it meant.
At what extend could Sunrise have been design to illustrate that Bavituximab works (which it did as shown by Bavi arm results) but not get approved by the FDA allowing its 'potential value' to be downplayed? A downplay that is of course now crossed by up-coming results from other clinical trial where ex-Sunrise Bavi patients perform much better then the others.
We must stop now with putting blame with either Ex-BoD (ES, CJ, DP)..;they are history... or RONIN ...RONIN contribute positively by accepting a settlement that as it looks now and without surprise is INDEED in all shareholders advantage. SO that door is closed and credit goes to who deserves credit and the NEW BoD INDEPENDENTLY takes over. Their best incentives are their shares and options.
We must now unite around making the HIGHEST FAIR VALUE of the R&D program and make sure the leverage ends up in our PPHM shares. We must leave no stone upturned, no opportunity go and no question marks pending.
EITHER PPHM R&D is worthless, then FULL DISCLOSURE OF ALL PIPELINE DATA, MOLECULE MANUFACTURING, IP, ETC IS NEEDED...EITHER its has VALUE and then we must see that in our shares in a meaningful way.
News 
Market Data 
Discover 
